Table 1

Summary of study subjects

IDCategorySexAgeGenotypeIDCategorySexAgeGenotype
1HCF49+/+21CFPSM46deltaF508/P67L
2HCF39+/+22CFPSF41deltaF508/R117C
3HCM32+/+23CFPSF57G542X/D1152H
4HCM23+/+24CFPSM34deltaF508/M1101K
5HCF28+/+25CFPSF29deltaF508/L1335P
6HCM26+/+26CFPSF48deltaF508/+
7HCM26R75Q/+27CFPSM26deltaF508/R117H
8HCM30+/+28CFPSM44deltaF508/3272_26A>G
9HCM22+/+29CFPSM46deltaF508/R117H 5T
10HCM22+/+30CFPSM48R347P/2753-2A>G
11HzF26deltaF508/+31CFPIM29deltaF508/deltaF508
12HzF54deltaF508/+32CFPIM29deltaF508/2194inA
13HzF24deltaF508/+33CFPIF40G551D/621+1 G>T
14HzF33deltaF508/+34CFPIM33deltaF508/deltaF508
15HzM25deltaF508/+35CFPIM27deltaF508/deltaF508
16HzF37deltaF508/+36CFPIM25deltaF508/deltaF508
17HzF49deltaF508/+37CFPIM27deltaF508/deltaF508
18HzM49deltaF508/+38CFPIM29deltaF508/deltaF508
19HzF55deltaF508/+
20HzM61deltaF508/+
  • CFPI, pancreatic-insufficient CF patients; CFPS, pancreatic-sufficient CF patients; HC, healthy controls; Hz, heterozygotes.

  • CFTR gene sequencing was performed for all subjects.22 23